Patients with hepatitis B‐associated HCC have a poor prognosis due to elevated levels of circRNA‐100338, which are linked to the activation of the mTOR signaling pathway in HCC via the circRNA‐100338/miR‐141‐3p/RHEB axis.538. The gene discussed is MTOR; the disease is hepatocellular carcinoma.